Comparison of the I-gel, Supreme and Proseal LMA in Paralyzed Patients
NCT ID: NCT01909297
Last Updated: 2013-07-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
35 participants
INTERVENTIONAL
2013-05-31
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
I-gel vs LMA Supreme in Laparoscopic Gynecological Surgery
NCT02923427
Comparison of Gastric Volume in I-gel and ProSeal Laryngeal Mask Airways
NCT07138092
Comparison of Size 1 I-gel and ProSeal Laryngeal Mask
NCT01704118
Comparison in Difficult Airway Scenario Induced in Patients With Laryngeal Mask Airway (LMA)-Classic™, LMA™ - Flexible and LMA - Proseal™
NCT02979171
Comparison of ProSeal Laryngeal Mask Airway, LTS-D and I-gel in Mechanically Ventilated Patients
NCT02877940
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ProSeal LMA
Supraglottic airway device
PROSEAL LMA
Size 3,4 or 5 supraglottic device with orogastric drainage tube
suprema LMA
Supraglottic airway device
SUPREMA LMA
Size 3,4 or 5, disposable supraglottic device with orogastric drainage tube
I-gel LMA
Supraglottic airway device
I-GEL LMA
Size 3,4,5 disposable supraglottic device with noninflatable cuff
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PROSEAL LMA
Size 3,4 or 5 supraglottic device with orogastric drainage tube
SUPREMA LMA
Size 3,4 or 5, disposable supraglottic device with orogastric drainage tube
I-GEL LMA
Size 3,4,5 disposable supraglottic device with noninflatable cuff
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* BMI 40
18 Years
60 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Inonu University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mukadder Sanli
assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
mukadder sanli, MD
Role: PRINCIPAL_INVESTIGATOR
Assistant Prof Dr
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Inonu University
Malatya, Turkey, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Singh I, Gupta M, Tandon M. Comparison of Clinical Performance of I-Gel with LMA-Proseal in Elective Surgeries. Indian J Anaesth. 2009 Jun;53(3):302-5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011/188
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.